Λεπτομέρειες βιβλιογραφικής εγγραφής
| Τίτλος: |
Patent Issued for Fast-NA for threat detection in high-throughput sequencing (USPTO 12603154). |
| Πηγή: |
Medical Letter on the CDC & FDA; 5/10/2026, p4513-4513, 1p |
| Θεματικοί όροι: |
Nucleotide sequencing, Real-time computing, Nucleotide sequence, Biosurveillance, Detection of microorganisms, Patents, Electronic data processing, Genetic code |
| Περίληψη: |
The article focuses on a patent assigned to RTX BBN Technologies Inc. for systems and methods designed to detect specific genetic sequences, particularly to identify and categorize snippets of malicious genetic material in real time during high-throughput sequencing. The patented technology addresses challenges in preventing the synthesis of harmful organisms by distinguishing unique genetic "signatures" of target organisms—such as malicious pathogens like SARS-CoV-2—from benign organisms using computational filters and probabilistic data structures. This approach enables rapid analysis of sequencing data to assess the presence and probability of target organisms in samples, potentially aiding in biosafety, diagnostics, and pathogen detection. The patent outlines both the method and system components for real-time genetic sequence analysis and signature identification. [Extracted from the article] |
|
Copyright of Medical Letter on the CDC & FDA is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Βάση Δεδομένων: |
Complementary Index |